| Dr George Cyrus Leach, MD | |
|
1968 Peachtree Road Nw, Atlanta, GA 30309 | |
| (404) 605-2800 | |
| (404) 351-5983 |
| Full Name | Dr George Cyrus Leach |
|---|---|
| Gender | Male |
| Speciality | Emergency Medicine |
| Location | 1968 Peachtree Road Nw, Atlanta, Georgia |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1043496979 | NPI | - | NPPES |
| Entity Name | The Emory Clinic Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1396798229 PECOS PAC ID: 8820901408 Enrollment ID: O20031110000503 |
News Archive
Head and neck cancer is an aggressive type of cancer that often grows back, despite patients undergoing harsh treatments.
President Barack Obama continued to lament the problems plaguing the federal online insurance marketplace, but he also scolded the Texas government for its resistance to the health law's Medicaid expansion, which, he said, left more than a million of the state's people uninsured.
Annals of Internal Medicine: Determinants Of Medical Expenditures In The Last 6 Months Of Life - Identifying factors about patients in the final six months of life that affect the level of care needed "may reveal opportunities for patient-centered interventions to predict and to reduce medical costs," write the authors, while noting that the study had "a large proportion of unexplained variation."
Merrimack Pharmaceuticals, Inc. announced today that the first patient has been dosed in a randomized Phase 2 clinical trial of MM-121, a fully human monoclonal antibody that targets ErbB3, combined with paclitaxel in the neoadjuvant setting of HER2-negative breast cancer patients.
› Verified 1 days ago
| Entity Name | Emory Medical Care Foundation Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1063452381 PECOS PAC ID: 4981501814 Enrollment ID: O20031217000968 |
News Archive
Head and neck cancer is an aggressive type of cancer that often grows back, despite patients undergoing harsh treatments.
President Barack Obama continued to lament the problems plaguing the federal online insurance marketplace, but he also scolded the Texas government for its resistance to the health law's Medicaid expansion, which, he said, left more than a million of the state's people uninsured.
Annals of Internal Medicine: Determinants Of Medical Expenditures In The Last 6 Months Of Life - Identifying factors about patients in the final six months of life that affect the level of care needed "may reveal opportunities for patient-centered interventions to predict and to reduce medical costs," write the authors, while noting that the study had "a large proportion of unexplained variation."
Merrimack Pharmaceuticals, Inc. announced today that the first patient has been dosed in a randomized Phase 2 clinical trial of MM-121, a fully human monoclonal antibody that targets ErbB3, combined with paclitaxel in the neoadjuvant setting of HER2-negative breast cancer patients.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr George Cyrus Leach, MD 1968 Peachtree Road Nw, Atlanta, GA 30309 Ph: (404) 605-2800 | Dr George Cyrus Leach, MD 1968 Peachtree Road Nw, Atlanta, GA 30309 Ph: (404) 605-2800 |
News Archive
Head and neck cancer is an aggressive type of cancer that often grows back, despite patients undergoing harsh treatments.
President Barack Obama continued to lament the problems plaguing the federal online insurance marketplace, but he also scolded the Texas government for its resistance to the health law's Medicaid expansion, which, he said, left more than a million of the state's people uninsured.
Annals of Internal Medicine: Determinants Of Medical Expenditures In The Last 6 Months Of Life - Identifying factors about patients in the final six months of life that affect the level of care needed "may reveal opportunities for patient-centered interventions to predict and to reduce medical costs," write the authors, while noting that the study had "a large proportion of unexplained variation."
Merrimack Pharmaceuticals, Inc. announced today that the first patient has been dosed in a randomized Phase 2 clinical trial of MM-121, a fully human monoclonal antibody that targets ErbB3, combined with paclitaxel in the neoadjuvant setting of HER2-negative breast cancer patients.
› Verified 1 days ago
Dr. Benjamin Aaron Levy, MD Emergency Medicine Medicare: Medicare Enrolled Practice Location: 5665 New Northside Dr Nw, Suite 200, Atlanta, GA 30328 Phone: 770-874-5400 | |
Essi I Peers, D.O. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 5665 New Northside Dr Ste 200, Atlanta, GA 30328 Phone: 770-874-5400 | |
Prince N Martin, Emergency Medicine Medicare: Not Enrolled in Medicare Practice Location: 5665 Peachtree Dunwoody Rd, Atlanta, GA 30342 Phone: 678-843-7001 | |
Melissa H White, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 80 Jesse Hill Jr Dr Se, Atlanta, GA 30303 Phone: 404-616-4307 Fax: 404-616-8022 | |
John H Lloyd, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 1358 Middlesex Ave Ne, Atlanta, GA 30306 Phone: 404-944-7563 | |
Dr. Vida M. Reklaitis, M.D. Emergency Medicine Medicare: Medicare Enrolled Practice Location: 1000 Johnson Ferry Rd Ne, Atlanta, GA 30342 Phone: 404-851-6936 Fax: 404-851-6024 | |
Dr. Steven M Joyce, M.D. Emergency Medicine Medicare: Not Enrolled in Medicare Practice Location: 2292 Peachtree Rd., Nw, Atlanta, GA 30309 Phone: 801-558-7791 |